These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 6619047)

  • 21. Pharmacokinetics of beta-lactam antibiotics.
    Bergan T
    Scand J Infect Dis Suppl; 1984; 42():83-98. PubMed ID: 6597564
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dose dependence of piperacillin pharmacokinetics.
    Bergan T; Williams JD
    Chemotherapy; 1982; 28(3):153-9. PubMed ID: 6212203
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantification of temocillin biliary excretion and gallbladder bile concentration in healthy subjects.
    Maudgal DP; Lanzini A; Northfield TC; Bridges C; Joseph AE
    Drugs; 1985; 29 Suppl 5():146-50. PubMed ID: 4029019
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pharmacokinetics after discontinuous intravenous administration of azlocillin].
    Naber K; Adam D
    Arzneimittelforschung; 1983; 33(3):429-32. PubMed ID: 6683518
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Temocillin concentrations in human tissues.
    Gould JG; Meikle G; Cooper DL; Horton R
    Drugs; 1985; 29 Suppl 5():167-70. PubMed ID: 3928320
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal clearance of temocillin in volunteers.
    Overbosch D; van Gulpen C; Mattie H
    Drugs; 1985; 29 Suppl 5():128-34. PubMed ID: 4029016
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pharmacokinetics of mezlocillin. Comparison with ampicillin and influence of probenecid (author's transl)].
    Verbist L; Tjandramaga TB; Verbesselt R; de Schepper PJ
    Nouv Presse Med; 1982 Feb; 11(5 Pt 2):347-52. PubMed ID: 6460974
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kinetics of mezlocillin and carbenicillin.
    Pancoast SJ; Neu HC
    Clin Pharmacol Ther; 1978 Jul; 24(1):108-16. PubMed ID: 657712
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics and tissue penetration of Timentin: a simultaneous study of serum, urine, lymph, suction blister and subcutaneous thread fluid.
    Walstad RA; Hellum KB; Thurmann-Nielsen E; Dale LG
    J Antimicrob Chemother; 1986 May; 17 Suppl C():71-80. PubMed ID: 3722049
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of protein binding on penetration of beta-lactams into rabbit peripheral lymph.
    Woodnutt G; Berry V; Mizen L
    Antimicrob Agents Chemother; 1995 Dec; 39(12):2678-83. PubMed ID: 8593001
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The pharmacokinetics of ceftriaxone in serum, skin blister and thread fluid.
    Kalager T; Digranes A; Bergan T; Solberg CO
    J Antimicrob Chemother; 1984 May; 13(5):479-85. PubMed ID: 6330020
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lung tissue penetration of temocillin.
    Cowan W; Baird A; Sleigh JD; Gray JM; Leiper JM; Lawson DH
    Drugs; 1985; 29 Suppl 5():151-3. PubMed ID: 4029020
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potential role of temocillin in the treatment of biliary sepsis.
    Uwaydah M; Vartivarian S; Harakeh H; Awdeh A; Najjar F
    Drugs; 1985; 29 Suppl 5():186-90. PubMed ID: 4029024
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison between the pharmacokinetic properties of mezlocillin when given intravenously as a bolus injection or as an infusion.
    Ohlsson H; Bergan T
    Arzneimittelforschung; 1979; 29(12a):1958-9. PubMed ID: 543900
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dose-dependent pharmacokinetics of azlocillin compared to mezlocillin.
    Bergan T; Thorsteinsson SB; Steingrimsson O
    Chemotherapy; 1982; 28(3):160-70. PubMed ID: 6212204
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of azlocillin after discontinuous intravenous administration of high dose.
    Naber KG; Adam D
    J Antimicrob Chemother; 1983 May; 11 Suppl B():115-20. PubMed ID: 6619021
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Temocillin elimination in patients with varying degrees of renal failure.
    Wright N; Wise R; Price JD
    J Antimicrob Chemother; 1983 May; 11(5):481-4. PubMed ID: 6874633
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thrice-weekly temocillin administered after each dialysis session is appropriate for the treatment of serious Gram-negative infections in haemodialysis patients.
    Vandecasteele SJ; Miranda Bastos AC; Capron A; Spinewine A; Tulkens PM; Van Bambeke F
    Int J Antimicrob Agents; 2015 Dec; 46(6):660-5. PubMed ID: 26603304
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human pharmacokinetics and antimicrobial activities of the temocillin epimers.
    Guest EA; Horton R; Mellows G; Slocombe B; Swaisland AJ; Tasker TC; White AR
    Drugs; 1985; 29 Suppl 5():154-61. PubMed ID: 4029021
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human pharmacokinetics of temocillin (BRL 17421) side chain epimers.
    Guest EA; Horton R; Mellows G; Slocombe B; Swaisland AJ; Tasker TC
    J Antimicrob Chemother; 1985 Mar; 15(3):327-36. PubMed ID: 3997707
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.